Frank Boschelli

3.7k total citations
69 papers, 2.6k citations indexed

About

Frank Boschelli is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Frank Boschelli has authored 69 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 24 papers in Organic Chemistry and 20 papers in Hematology. Recurrent topics in Frank Boschelli's work include Quinazolinone synthesis and applications (21 papers), Chronic Myeloid Leukemia Treatments (20 papers) and Synthesis and biological activity (12 papers). Frank Boschelli is often cited by papers focused on Quinazolinone synthesis and applications (21 papers), Chronic Myeloid Leukemia Treatments (20 papers) and Synthesis and biological activity (12 papers). Frank Boschelli collaborates with scholars based in United States, Canada and Italy. Frank Boschelli's co-authors include Diane H. Boschelli, Kim Arndt, Jennifer M. Golas, Judy Lucas, Fei Ye, Biqi Wu, Carlo Gambacorti‐Passerini, Barna Dey, Dennis Powell and Philip Frost and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Frank Boschelli

69 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Boschelli United States 28 1.4k 823 654 581 579 69 2.6k
William C. Shakespeare United States 29 1.8k 1.3× 666 0.8× 816 1.2× 933 1.6× 461 0.8× 59 3.2k
Diane H. Boschelli United States 28 1.2k 0.8× 452 0.5× 1.4k 2.1× 581 1.0× 303 0.5× 87 2.7k
David C. Dalgarno United States 33 2.4k 1.8× 557 0.7× 353 0.5× 828 1.4× 377 0.7× 71 3.6k
Lily L. Remsing Rix United States 19 902 0.7× 465 0.6× 260 0.4× 429 0.7× 358 0.6× 28 1.8k
Patricia Pellicena United States 18 2.0k 1.4× 1.3k 1.6× 395 0.6× 579 1.0× 879 1.5× 23 3.6k
Judy Lucas United States 34 2.2k 1.6× 443 0.5× 1.1k 1.6× 1000 1.7× 480 0.8× 69 4.1k
Gabriele Fendrich Switzerland 18 943 0.7× 543 0.7× 337 0.5× 216 0.4× 365 0.6× 30 1.7k
Louis J. Lombardo United States 22 548 0.4× 494 0.6× 567 0.9× 252 0.4× 356 0.6× 54 1.7k
Daniel K. Treiber United States 16 2.6k 1.9× 443 0.5× 287 0.4× 561 1.0× 282 0.5× 24 3.3k
Sandra W. Cowan‐Jacob Switzerland 30 1.9k 1.4× 2.2k 2.7× 863 1.3× 801 1.4× 1.6k 2.8× 51 4.6k

Countries citing papers authored by Frank Boschelli

Since Specialization
Citations

This map shows the geographic impact of Frank Boschelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Boschelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Boschelli more than expected).

Fields of papers citing papers by Frank Boschelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Boschelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Boschelli. The network helps show where Frank Boschelli may publish in the future.

Co-authorship network of co-authors of Frank Boschelli

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Boschelli. A scholar is included among the top collaborators of Frank Boschelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Boschelli. Frank Boschelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Redaelli, Sara, Pietro Perini, Monica Ceccon, et al.. (2015). In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib. Journal of Hematology & Oncology. 8(1). 81–81. 18 indexed citations
2.
Zapf, Christoph W., Jonathan D. Bloom, Russell G. Dushin, et al.. (2011). Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activity. Bioorganic & Medicinal Chemistry Letters. 21(11). 3411–3416. 14 indexed citations
3.
Hebbard, Lionel, Jonathon Golas, Junko Sawada, et al.. (2010). Control of mammary tumor differentiation by SKI-606 (bosutinib). Oncogene. 30(3). 301–312. 25 indexed citations
4.
Messersmith, Wells A., N.V. Rajeshkumar, Aik Choon Tan, et al.. (2009). Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Molecular Cancer Therapeutics. 8(6). 1484–1493. 34 indexed citations
5.
Boschelli, Frank, et al.. (2009). SKI-606 and beyond. 1(8). 4 indexed citations
6.
Zhang, Nan, Biqi Wu, Diane H. Boschelli, Jennifer M. Golas, & Frank Boschelli. (2009). 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(17). 5071–5074. 6 indexed citations
7.
Pong, Kevin, Cathleen Gonzales, Yi Chen, et al.. (2009). Neuroprotective Profile of Novel Src Kinase Inhibitors in Rodent Models of Cerebral Ischemia. Journal of Pharmacology and Experimental Therapeutics. 331(3). 827–835. 32 indexed citations
8.
Coughlin, Christina, Marisa Dolled‐Filhart, Charles Zacharchuk, et al.. (2008). Src pathway activation correlates with treatment resistance in breast cancer and identifies patient subsets predicted to benefit from Src inhibition. Clinical Cancer Research. 14. 1 indexed citations
9.
Ozawa, Yukiyasu, Ann H. Williams, Myka L. Estes, et al.. (2008). Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leukemia Research. 32(6). 893–903. 47 indexed citations
10.
Vultur, Adina, et al.. (2007). SKI-606, a novel Src kinase inhibitor, blocks migration and invasion of human breast cancer cells. Cancer Research. 67. 3251–3251. 1 indexed citations
11.
Wu, Biqi, Ana Carolina Barrios Sosa, Diane H. Boschelli, et al.. (2006). 7-(Aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles as new Src kinase inhibitors: Addition of water solubilizing groups. Bioorganic & Medicinal Chemistry Letters. 16(15). 3993–3997. 12 indexed citations
12.
Boschelli, Diane H., et al.. (2005). Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles. Bioorganic & Medicinal Chemistry Letters. 15(21). 4681–4684. 12 indexed citations
13.
Zhao, Qiang, Frank Boschelli, Avrom J. Caplan, & Kim Arndt. (2004). Identification of a Conserved Sequence Motif That Promotes Cdc37 and Cyclin D1 Binding to Cdk4. Journal of Biological Chemistry. 279(13). 12560–12564. 42 indexed citations
14.
Boschelli, Diane H., Dennis Powell, Jennifer M. Golas, & Frank Boschelli. (2003). Inhibition of Src kinase activity by 4-anilino-5,10-dihydro-pyrimido[4,5-b]quinolines. Bioorganic & Medicinal Chemistry Letters. 13(18). 2977–2980. 16 indexed citations
15.
Talpaz, Moshe, et al.. (2002). Novel Tyrosine Kinase Inhibitors Suppress BCR-ABL Signaling and Induce Apoptosis in STI-571 Sensitive and Resistant CML Cells. Blood. 100(11). 143416. 4 indexed citations
16.
Zhang, Nan, Biqi Wu, Allan Wissner, et al.. (2002). 4-Anilino-3-cyanobenzo[g]quinolines as Kinase Inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(3). 423–425. 13 indexed citations
17.
Boschelli, Diane H., Daniel Wang, Fei Ye, et al.. (2002). Inhibition of Src kinase activity by 4-anilino-7-thienyl-3-quinolinecarbonitriles. Bioorganic & Medicinal Chemistry Letters. 12(15). 2011–2014. 22 indexed citations
18.
Wang, Yanong D., Karen Miller, Diane H. Boschelli, et al.. (2000). Inhibitors of Src tyrosine kinase: the preparation and structure–activity relationship of 4-anilino-3-cyanoquinolines and 4-anilinoquinazolines. Bioorganic & Medicinal Chemistry Letters. 10(21). 2477–2480. 58 indexed citations
19.
Dey, Barna, et al.. (1996). The Ydj1 molecular chaperone facilitates formation of active p60v-src in yeast.. Molecular Biology of the Cell. 7(1). 91–100. 56 indexed citations
20.
Dey, Barna, James J. Lightbody, & Frank Boschelli. (1996). CDC37 is required for p60v-src activity in yeast.. Molecular Biology of the Cell. 7(9). 1405–1417. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William C. Shakespeare Breakdown of academic impact, for papers by Diane H. Boschelli Breakdown of academic impact, for papers by David C. Dalgarno Breakdown of academic impact, for papers by Lily L. Remsing Rix Breakdown of academic impact, for papers by Patricia Pellicena Breakdown of academic impact, for papers by Judy Lucas Breakdown of academic impact, for papers by Gabriele Fendrich Breakdown of academic impact, for papers by Louis J. Lombardo Breakdown of academic impact, for papers by Daniel K. Treiber Breakdown of academic impact, for papers by Sandra W. Cowan‐Jacob
Rankless by CCL
2026